Molecular docking studies of 4-nitromonosubstituted chalcone derivatives as cyclooxygenase-2 (COX-2) inhibitors
Open Access
- 1 January 2023
- conference paper
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2872 (1)
Abstract
A series of 4-nitrochalcone derivatives was designed and docked into the crystal structures of the cyclooxygenase-2 (COX-2) enzyme to calculate the binding affinity of each derivative within the protein active site. We employed the non-selective COX-2 inhibitor ibuprofen and the selective COX-2 inhibitor celecoxib as references to compare the interaction and likely inhibitory impact of the 4-nitrochalcone derivatives. Ibuprofen showed lower affinity values than 3’-COOH-4-nitrochalcone, 3’-CF3-4-nitrochalcone and 3’-NO2-4-nitrochalcone. These derivatives act in the same way as celecoxib at the active site of COX-2. This information could be useful in the development of monosubstituted 4-nitrochalcone derivatives as anti-inflammatory compounds.Keywords
This publication has 32 references indexed in Scilit:
- Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets PerspectivesCurrent Topics in Medicinal Chemistry, 2017
- QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activityEuropean Journal of Medicinal Chemistry, 2017
- Enzymes of the Cyclooxygenase Pathways of Prostanoid BiosynthesisChemical Reviews, 2011
- The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: The first clinical candidateBioorganic & Medicinal Chemistry Letters, 2010
- Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effectEuropean Journal of Medicinal Chemistry, 2010
- Cyclooxygenase in normal human tissues – is COX‐1 really a constitutive isoform, and COX‐2 an inducible isoform?Journal of Cellular and Molecular Medicine, 2009
- COX-2 Inhibitors and Cardiovascular RiskJournal of Cardiovascular Pharmacology, 2007
- Cyclooxygenase isozymes and their gene structures and expressionProstaglandins & Other Lipid Mediators, 2002
- Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?BMJ, 2002
- COX-2 Specific Inhibitors Offer Improved Advantages Over Traditional NSAIDsOrthopedics, 2000